Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Wed, Apr 23, 2025 08:32 AM All times are UTC

Follow Series

©Econometrics LLC 2025. All Rights Reserved.

Andrew George

Andrew George was appointed Deputy Vice-Chancellor (Education and International) on 1 October 2013. He joined Brunel from Imperial College London where he was Professor of Molecular Immunology and Director of the Graduate School and the School of Professional Development.

Andrew George did his first degree at the University of Cambridge, before going on to the Tenovus Laboratories in the University of Southampton to do his PhD with Professor Freda Stevenson, developing a vaccine for B cell lymphoma. He was awarded a Beit Memorial Fellowship and stayed in Southampton for his first postdoctoral period, before going to Dr David Segal’s laboratory in the National Institutes of Health (NIH), Bethesda, USA, where he used recombinant techniques to generate novel antibody molecules. In 1992 he returned to the UK as a lecturer at the Royal Postgraduate Medical School, Hammersmith Hospital, which merged with Imperial College in 1997.

Andrew’s research has sought to understand and manipulate the immune system in order to treat disease, in particular to prevent the rejection of transplanted organs. He has also used mathematical models to understand how the immune system functions. In addition to his research, he has been involved in the ethical conduct and regulation of research. He is currently Chair of the UK’s National Research Ethics Advisors’ Panel and is on the Clinical Trials, Biologicals and Vaccines Expert Advisory Group for the Commission of Human Medicines/MHRA. He is a Governor of Richmond Adult Community College and the John Hampden School.

We should use placebos more often, especially in surgery

Mar 10, 2016 14:58 pm UTC| Health

Youre ill, probably scared, not sure of the future. Your doctor talks to you about your condition and says that, unfortunately, there are no effective treatments. However, she knows of a clinical trial for a new drug, and...

Economy

Trump Calms Markets with Assurances on Fed and Tariffs

President Trump has gone to reassure markets by indicating that he has no plans to remove Federal Reserve Chairman Jerome Powell from office, walking back previous criticisms. While he once referred to Powell as a major...

BOJ Likely to Hold Rates Until July Amid Tariff Uncertainty, Economists Say

The Bank of Japan is expected to keep its key interest rate unchanged through June, according to a Reuters survey conducted from April 1421. Out of 56 economists, 84% anticipate no rate change at the April 30-May 1 and...

Asian Currencies Rise as Trump Eases Fed, Tariff Tensions

Most Asian currencies strengthened on Wednesday after U.S. President Donald Trump softened his stance on the Federal Reserve and signaled openness to easing trade tariffs on China. Meanwhile, the Japanese yen weakened...

Oil Prices Climb as U.S. Sanctions Iran, Trump Eases Fed Pressure

Oil prices extended gains in early Asian trading Wednesday following fresh U.S. sanctions on Iran and a larger-than-expected drop in U.S. crude inventories. Market sentiment was also lifted after President Donald Trump...

Asian Markets Rally on Hopes of Eased U.S.-China Tariffs

Asian stocks surged on Wednesday, buoyed by Wall Street gains after U.S. President Donald Trump suggested potential reductions in trade tariffs against China. His remarks sparked investor optimism, despite lingering...

Politics

Peter Dutton Pledges Boost in Australia’s Defence Spending Ahead of Election

Australias opposition leader Peter Dutton has vowed to raise defence spending to 3% of GDP within a decade if elected, aiming to strengthen national security amid growing global tensions and pressure from the Trump...

Elon Musk Clarifies Role at DOGE as Tesla Faces Investor Concerns

Tesla Inc (NASDAQ:TSLA) CEO Elon Musk clarified Tuesday that he is not stepping down from the Department of Government Efficiency (DOGE), but is merely reducing his time commitment. Responding to a post on X, Musk stated,...

Trump’s Approval Hits New Low Amid Public Backlash Over Power Moves

U.S. President Donald Trumps approval rating has dropped to 42%, the lowest since his return to the White House, according to a recent Reuters/Ipsos poll. The decline reflects growing public concern over his efforts to...

Over 200 University Leaders Slam Trump Administration Over Political Interference

More than 200 presidents from U.S. colleges and universities, including Harvard, Princeton, and Columbia, have jointly denounced what they call unprecedented political interference by the Trump administration in higher...

Thai Rice Exports at Risk Amid US Tariffs and India’s Market Return

Thailands rice industry is facing a double blow as U.S. President Donald Trumps tariff threats loom and India resumes rice exports, driving prices down. Daeng Donsingha, a 70-year-old Thai farmer, struggles to stay afloat...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

China’s Tech Giants Stockpile Nvidia H20 AI Chips Ahead of U.S. Export Ban

Chinas leading tech firms, including ByteDance, Alibaba (HK:9988), and Tencent (HK:0700), have reportedly stockpiled close to one million units of Nvidias (NASDAQ:NVDA) H20 AI chips in anticipation of tightened U.S. export...

BMW to Integrate Chinese AI from DeepSeek in China-Made Vehicles

German automotive giant BMW (ETR:BMWG) announced it will begin integrating artificial intelligence (AI) developed by Chinese startup DeepSeek into its upcoming vehicle models in China starting later this year. The...

Tesla’s Optimus Robot Faces Delays Amid China’s Rare Earth Export Curbs

Tesla CEO Elon Musk revealed that production of the companys Optimus humanoid robot has been delayed due to Chinas new export restrictions on rare earth magnetscritical components in robotics and electric vehicles....

Amazon Pauses Some AWS Data Center Leases Amid AI Demand Slowdown

Amazon.com (NASDAQ:AMZN) has reportedly paused portions of its data center leasing negotiations for Amazon Web Services (AWS), signaling a potential slowdown in demand from major artificial intelligence (AI) clients,...

Nintendo Faces Tariff Hurdles Ahead of Switch 2 Launch

Nintendo is preparing to launch the highly anticipated Switch 2 on June 5, marking eight years since the original Switch debuted. The console, which sold over 150 million units globally, became a pandemic-era favorite....